Nathalie Bastien mainly focuses on Virology, Coronavirus, Gene, Virus and Internal medicine. Her study brings together the fields of Retrospective cohort study and Virology. She has researched Coronavirus in several fields, including Nidovirales, Severe acute respiratory syndrome and Airborne transmission.
Her work investigates the relationship between Gene and topics such as Molecular biology that intersect with problems in Protein oligomerization, Viral nucleocapsid, Binding site and Protein–protein interaction. Her work deals with themes such as Vero cell, Viral culture, Real-time polymerase chain reaction, Infectivity and Infectious dose, which intersect with Internal medicine. Nathalie Bastien works mostly in the field of Influenza a, limiting it down to concerns involving Trivalent influenza vaccine and, occasionally, Odds ratio and Confidence interval.
Her primary areas of investigation include Virology, Virus, Immunology, Influenza a and Influenza A virus. Her Influenza A virus subtype H5N1 study in the realm of Virus interacts with subjects such as Pandemic. Her Immunology research incorporates themes from Young adult, Peripheral blood mononuclear cell and Respiratory system.
Her Influenza a research is multidisciplinary, incorporating elements of Clade and Epidemiology. In Hemagglutination assay, Nathalie Bastien works on issues like Odds ratio, which are connected to Confidence interval, Vero cell, Infectivity and Infectious dose. Her work in the fields of Internal medicine, such as Interquartile range, intersects with other areas such as Coronavirus.
Nathalie Bastien focuses on Virology, Influenza a, Confidence interval, Influenza vaccine and Vaccine strain. Her Virology study frequently draws parallels with other fields, such as Antigen. Her Influenza a research includes themes of Cohort effect and Outbreak.
Her research in Confidence interval intersects with topics in Gastroenterology, Viral culture, Real-time polymerase chain reaction and Interquartile range. The concepts of her Vaccination study are interwoven with issues in Influenzavirus B and Antigenic distance. Nathalie Bastien focuses mostly in the field of Epidemiology, narrowing it down to topics relating to Original antigenic sin and, in certain cases, Odds ratio.
Her main research concerns Confidence interval, Odds ratio, Influenza a, Virology and Influenza vaccine. Her Confidence interval research is multidisciplinary, relying on both Gastroenterology, Vero cell and Interquartile range. Her biological study spans a wide range of topics, including Infectivity, Viral culture, Real-time polymerase chain reaction and Infectious dose.
Her research integrates issues of Vaccine-preventable diseases, Live attenuated influenza vaccine and Antigen in her study of Influenza a. Her study in Epidemiology extends to Virology with its themes. Her work on Influenza virus vaccine is typically connected to Current season as part of general Influenza vaccine study, connecting several disciplines of science.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Genome Sequence of the SARS-associated Coronavirus
Marco A. Marra;Steven J. M. Jones;Caroline R. Astell;Robert A. Holt.
Science (2003)
Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples
Jared Bullard;Jared Bullard;Kerry Dust;Duane Funk;Duane Funk;James E Strong;James E Strong.
Clinical Infectious Diseases (2020)
Detection of Airborne Severe Acute Respiratory Syndrome (SARS) Coronavirus and Environmental Contamination in SARS Outbreak Units
Timothy F. Booth;Bill Kournikakis;Nathalie Bastien;Jim Ho.
The Journal of Infectious Diseases (2005)
Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses
Danuta M. Skowronski;Naveed Z. Janjua;Gaston De Serres;Suzana Sabaiduc.
PLOS ONE (2014)
Human Bocavirus infection, Canada.
Nathalie Bastien;Ken Brandt;Kerry Dust;Diane Ward.
Emerging Infectious Diseases (2006)
Triple reassortant H3N2 influenza A viruses, Canada, 2005.
Christopher W. Olsen;Alexander I. Karasin;Suzanne Carman;Yan Li.
Emerging Infectious Diseases (2006)
Human Metapneumovirus Infection in the Canadian Population
Nathalie Bastien;Diane Ward;Paul Van Caeseele;Ken Brandt.
Journal of Clinical Microbiology (2003)
Human coronavirus NL63 infection in Canada
Nathalie Bastien;Kelly Anderson;Laura Hart;Paul Van Caeseele.
The Journal of Infectious Diseases (2005)
Mass Spectrometric Characterization of Proteins from the SARS Virus A Preliminary Report
Oleg Krokhin;Yan Li;Anton Andonov;Heinz Feldmann;Heinz Feldmann.
Molecular & Cellular Proteomics (2003)
Analysis of multimerization of the SARS coronavirus nucleocapsid protein
Runtao He;Frederick Dobie;Melissa Ballantine;Andrew Leeson.
Biochemical and Biophysical Research Communications (2004)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Public Health Agency of Canada
University of British Columbia
University of British Columbia
University of British Columbia
Université Laval
Canadian Blood Services
Public Health Agency of Canada
University of Toronto
National Institutes of Health
University of Manitoba
University of Évry Val d'Essonne
University of the Basque Country
University of Cagliari
North Carolina State University
University of Miami
Oregon State University
University of Lausanne
Washington State University
National Institute for Environmental Studies
Cornell University
University of Amsterdam
University of Leicester
International AIDS Vaccine Initiative
University of Manitoba
Cleveland Clinic
Memorial Sloan Kettering Cancer Center